Comparison of Methods for Delivering a Lifestyle Modification Program for Obese Patients A Randomized Trial

被引:111
作者
Digenio, Andres G.
Mancuso, James P.
Gerber, Robert A.
Dvorak, Roman V.
机构
[1] Pfizer, S Lyme, CT USA
[2] Pfizer Global Res & Dev, Cardiovasc & Metab, New London, CT USA
关键词
WEIGHT; OVERWEIGHT; PHARMACOTHERAPY; INTERVENTION; RISK;
D O I
10.7326/0003-4819-150-4-200902170-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Physicians frequently prescribe medications for weight loss but offer minimal lifestyle counseling despite the additional benefits of combining both interventions. Objective: To compare 5 methods of delivering a lifestyle modification program to obese patients receiving sibutramine. Design: Randomized, 6-month, open-label study. Participants were assigned to intervention groups by using a computer-generated schedule of randomly permuted blocks. Block length was 5. Setting: 12 independent research clinics with experience running obesity trials. Patients: 376 patients with obesity ( body mass index >= 30 and < 40 kg/m(2)). Intervention: High-frequency face-to-face lifestyle modification counseling (HF-F2F) (n = 74), low-frequency face-to-face counseling (LF-F2F) ( n = 76), high-frequency telephone counseling (HFTEL) ( n = 76), high-frequency e-mail counseling (HF-EMAIL) ( n = 74), or no dietitian contact (self-help [ SELF]) ( n = 76). All participants received sibutramine, 10 mg/d; a lifestyle manual; and access to a weight-loss Web site. Measurements: Percentage change in body weight at 6 months was the primary outcome. Secondary end points included changes in waist circumference; lipid, glucose, and insulin levels; blood pressure; weight-related symptoms; and quality of life at 6 months. Results: At 6 months, the mean weight loss, relative to baseline, in the HF-F2F and HF-TEL groups was similar (8.9% [95% CI, 8.0% to 9.8%] and 7.7% [ CI, 6.8% to 8.7%]) and significantly greater than that in the other groups (LF-F2F, 6.4% [ CI, 5.4% to 7.3%]; HF-EMAIL, 5.9% [ CI, 5.0% to 6.8%]; and SELF, 5.2% [ CI, 4.3% to 6.1%]). All groups showed significant improvements in waist circumference, high-density lipoprotein cholesterol and triglyceride levels, and measures of quality of life and weight-related symptoms. There were no serious adverse events and no differences in minor events among groups. Limitation: Most participants were women, and the attrition rate was 30%. Conclusion: High-frequency telephone contact with a dietitian was similar to HF-F2F contact for supporting lifestyle modification in obese patients trying to lose weight. The findings might be used by providers and health systems to promote healthy lifestyle changes for their patients.
引用
收藏
页码:255 / U54
页数:12
相关论文
共 15 条
[1]   Comparison of a phone vs clinic approach to achieve 10% weight loss [J].
Donnelly, J. E. ;
Smith, B. K. ;
Dunn, L. ;
Mayo, M. M. ;
Jacobsen, D. J. ;
Stewart, E. E. ;
Gibson, C. ;
Sullivan, D. K. .
INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (08) :1270-1276
[2]   The feasibility of using Internet support for the maintenance of weight loss [J].
Harvey-Berino, J ;
Pintauro, SJ ;
Gold, EC .
BEHAVIOR MODIFICATION, 2002, 26 (01) :103-116
[3]   The effects of a telephone-based intervention on weight loss [J].
Hellerstedt, WL ;
Jeffery, RW .
AMERICAN JOURNAL OF HEALTH PROMOTION, 1997, 11 (03) :177-182
[4]   Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J].
Knowler, WC ;
Barrett-Connor, E ;
Fowler, SE ;
Hamman, RF ;
Lachin, JM ;
Walker, EA ;
Nathan, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) :393-403
[5]   Development of a brief measure to assess quality of life in obesity [J].
Kolotkin, RL ;
Crosby, RD ;
Kosloski, KD ;
Williams, GR .
OBESITY RESEARCH, 2001, 9 (02) :102-111
[6]   The disease burden associated with overweight and obesity [J].
Must, A ;
Spadano, J ;
Coakley, EH ;
Field, AE ;
Colditz, G ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1523-1529
[7]   Prevalence of overweight and obesity in the United States, 1999-2004 [J].
Ogden, CL ;
Carroll, MD ;
Curtin, LR ;
McDowell, MA ;
Tabak, CJ ;
Flegal, KM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (13) :1549-1555
[8]   Performance of two self-report measures for evaluating obesity and weight loss [J].
Patrick, DL ;
Bushnell, DM ;
Rothman, M .
OBESITY RESEARCH, 2004, 12 (01) :48-57
[9]   Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial [J].
Pi-Sunyer, F ;
Aronne, LJ ;
Heshmati, HM ;
Devin, J ;
Rosenstock, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (07) :761-775
[10]  
Pi-Sunyer FX, 1998, OBES RES, V6, p51S